Clinical trial
Semaglutide and Vascular Regeneration in People With Diabetes and/or Obesity
NCT05870462 is registered in ClinicalTrials.gov with Canadian Medical and Surgical Knowledge Translation Research Group as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Semaglutide and Vascular Regeneration in People With Diabetes and/or Obesity
- Lead sponsor
- Canadian Medical and Surgical Knowledge Translation Research Group
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- April 29, 2023
- Completion date
- December 31, 2024
- Enrollment
- 100 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.